Central Trust Company’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20
Closed -$3.98K 1433
2023
Q3
$3.98K Hold
20
﹤0.01% 1168
2023
Q2
$5.71K Hold
20
﹤0.01% 1084
2023
Q1
$4.34K Sell
20
-849
-98% -$165K ﹤0.01% 1128
2022
Q4
$179K Buy
869
+121
+16% +$30.6K 0.01% 542
2022
Q3
$208K Buy
748
+746
+37,300% +$190K 0.01% 517
2022
Q2
$0 Hold
2
﹤0.01% 1482
2022
Q1
$0 Buy
+2
New +$330 ﹤0.01% 1526

Other funds holding SWAV

Central Trust Company's SWAV Position: Q4 2023 in Review

Central Trust Company sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 20 shares — an estimated $3.98K sold.

Central Trust Company first reported a position in SWAV in Q1 2022 and held it in 7 quarters. The position peaked at $208K in Q3 2022. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

  • Central Trust Company reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Central Trust Company sold 20 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $3.98K.
  • Central Trust Company first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • Central Trust Company's Shockwave Medical, Inc. Common Stock position peaked at $208K in Q3 2022.
  • 427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Central Trust Company's 13F filing for Q4 2023, filed 24 Jan 2024.